| id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S18442 R78281 |
Lee (Controls exposed to TCAs), 2025 | Admission to neonatal intensive care unit (NICU) | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | exposed to other treatment, sick excluded | Adjustment: No Monotherapy: SSRI only |
0.81 [0.48;1.39] C excluded (control group) |
41/1,465 21/613 | 62 | 1,465 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18408 R77703 |
Lee (Controls unexposed, general pop), 2025 | Admission to neonatal intensive care unit (NICU) | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: Yes Monotherapy: SSRI only | 1.03 [0.74;1.43] | 41/1,465 8,566/463,440 | 8,607 | 1,465 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18131 R76225 |
Raviv, 2025 | Neonatal intensive care unit admission (NICU) | during pregnancy (anytime or not specified) | retrospective cohort | unexposed (general population or NOS) | Adjustment: No Monotherapy: no or not specified | 3.07 [2.59;3.65] C | 150/2,321 2,278/103,607 | 2,428 | 2,321 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18258 R76640 |
Cornet - SSRIs, 2024 | Delayed neonatal adaptation (presence of at least one of the following: 5min Apgar score ≤5; positive pressure ventilation or intubation during delivery room resuscitation; or admission to the NICU with respiratory distress requiring invasive or non-invasive ventilation) | late pregnancy | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: Yes Monotherapy: no or not specified | 2.14 [1.96;2.33] | 847/7,573 12,078/272,517 | 12,925 | 7,573 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S14988 R61341 |
Gover, 2023 | Delivery room advanced resuscitation | throughout pregnancy | retrospective cohort | unexposed (general population or NOS) | Adjustment: No Matched Monotherapy: no or not specified | 1.58 [0.24;10.61] C | 3/21 2/21 | 5 | 21 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S18233 R76476 |
Rommel, 2022 | Neonatal admission (inpatient contact with the first 28 days, excluding contact with the ICD-10 Z38 or Z76) | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed, sick | Adjustment: Yes Monotherapy: SSRI only Unexposed sick: intermediate history of illness/treatment (3-12 months before pregnancy) | 1.43 [1.35;1.51] | -/16,429 -/23,676 | - | 16,429 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S13112 R49960 |
Marks - Sertraline (Controls exposed to Bupropion), 2021 | Neonatal intensive care unit admission | during pregnancy (anytime or not specified) | retrospective cohort | exposed to other treatment, sick | Adjustment: Yes Monotherapy: substance alone among all Antidep (SSRI, SNRI, ...) | 1.08 [0.81;1.45] | 384/1,653 91/406 | 475 | 1,653 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S10057 R36520 |
Ulbrich, 2021 | Neonatal intensive care unit (NICU) admission | 3rd trimester | retrospective cohort | unexposed (general population or NOS) | Adjustment: Yes Monotherapy: no or not specified | 2.13 [1.18;3.32] | 20/163 282/4,770 | 302 | 163 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S5461 R24127 |
Levy, 2020 | Neonatal intensive care unit | throughout pregnancy | retrospective cohort | unexposed (general population or NOS) | Adjustment: No Matched Monotherapy: no or not specified | 8.34 [3.78;18.39] C | 44/82 10/82 | 54 | 82 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S12918 R49003 |
Gungor (Controls exposed to Mirtazapine), 2019 | Staying at Neonatal Intensive Care Unit (NCU) | during pregnancy (anytime or not specified) | prospective cohort | exposed to other treatment, sick excluded | Adjustment: No Monotherapy: SSRI only |
1.48 [0.27;8.06] C excluded (control group) |
7/40 2/16 | 9 | 40 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S8158 R25130 |
Gungor (Controls unexposed, disease free), 2019 | Staying at Neonatal Intensive Care Unit (NCU) | during pregnancy (anytime or not specified) | prospective cohort | unexposed, disease free excluded | Adjustment: No Monotherapy: SSRI only |
0.48 [0.15;1.62] C excluded (control group) |
7/40 7/23 | 14 | 40 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S8159 R25136 |
Gungor (Controls unexposed, sick), 2019 | Staying at Neonatal Intensive Care Unit (NCU) | during pregnancy (anytime or not specified) | prospective cohort | unexposed, sick | Adjustment: No Monotherapy: SSRI only Unexposed sick: old history of illness/treatment (> 12 months before pregnancy) or not specified | 1.41 [0.33;6.10] C | 7/40 3/23 | 10 | 40 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S7921 R23970 |
Giardinelli (Controls unexposed, disease free), 2018 | Neonatal intensive care unit | during pregnancy (anytime or not specified) | prospective cohort | unexposed, disease free excluded | Adjustment: No Monotherapy: no or not specified |
5.93 [0.27;130.35] C excluded (control group) |
2/24 0/26 | 2 | 24 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S7916 R23961 |
Giardinelli (Controls unexposed, sick), 2018 | Neonatal intensive care unit | during pregnancy (anytime or not specified) | prospective cohort | unexposed, sick | Adjustment: No Monotherapy: no or not specified Unexposed sick: recent illness/treatment (during or juste before pregnancy or treatment stopped in view of pregnancy) | 0.95 [0.12;7.41] C | 2/24 2/23 | 4 | 24 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S7569 R22727 |
Hogue, 2017 | Neonatal Intensive Care Unit admission (in full-term neonates) | during pregnancy (anytime or not specified) | retrospective cohort | unexposed (general population or NOS) | Adjustment: Yes Monotherapy: SSRI only | 4.90 [1.30;18.70] | 16/117 4/116 | 20 | 117 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S10062 R36569 |
Bracero, 2016 | Neonatal intensive care unit (NICU) admissions | days before delivery | retrospective cohort | unexposed, sick | Adjustment: No Monotherapy: no or not specified | 12.17 [2.00;73.89] C | 4/6 12/85 | 16 | 6 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S7570 R22768 |
Kivistö, 2016 | Neonatal intensive care | during pregnancy (anytime or not specified) | retrospective cohort | unexposed (general population or NOS) | Adjustment: Yes Monotherapy: SSRI only | 2.20 [1.67;2.88] | 82/358 2,431/24,402 | 2,513 | 358 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S5430 R16579 |
Norby, 2016 | Admission to Neonatal intensive care unit | 3rd trimester | population based cohort retrospective | unexposed (general population or NOS) | Adjustment: Yes Monotherapy: no or not specified | 1.70 [1.60;1.80] | 1,501/9,100 59,210/718,533 | 60,711 | 9,100 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S14992 R61351 |
Robinson-Wolrath, 2016 | Need for any resuscitation | during pregnancy (anytime or not specified) | retrospective cohort | unexposed (general population or NOS) | Adjustment: Yes Monotherapy: SSRI only | 2.20 [1.67;2.89] | -/- -/- | - | - |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S8053 R24537 |
Salisbury (Controls unexposed, disease free), 2016 | Neonatal intensive care unit admission | during pregnancy (anytime or not specified) | prospective cohort | unexposed, disease free excluded | Adjustment: No Monotherapy: no or not specified |
2.02 [0.54;7.58] C excluded (control group) |
6/52 4/66 | 10 | 52 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S8071 R24580 |
Salisbury (Controls unexposed, sick), 2016 | Neonatal intensive care unit admission | during pregnancy (anytime or not specified) | prospective cohort | unexposed, sick | Adjustment: No Monotherapy: no or not specified Unexposed sick: old history of illness/treatment (> 12 months before pregnancy) or not specified | 7.17 [0.83;61.77] C | 6/52 1/56 | 7 | 52 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S6107 R15971 |
Malm (Controls unexposed, disease free), 2015 | Neonatal care unit | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed, disease free excluded | Adjustment: Yes Monotherapy: no or not specified |
1.38 [1.29;1.48] excluded (control group) |
2,405/15,729 3,032/31,394 | 5,437 | 15,729 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S5374 R15955 |
Malm (Controls unexposed, sick), 2015 | Neonatal care unit | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed, sick | Adjustment: Yes Monotherapy: no or not specified Unexposed sick: intermediate history of illness/treatment (3-12 months before pregnancy) | 1.24 [1.14;1.35] | 2,405/15,729 1,160/9,652 | 3,565 | 15,729 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S12947 R49133 |
Engelstad (Controls unexposed, disease free), 2014 | Admission to the neonatal intensive care unit (NICU) | during pregnancy (anytime or not specified) | retrospective cohort | unexposed, disease free excluded | Adjustment: Yes Monotherapy: SSRI only |
1.14 [0.69;1.91] excluded (control group) |
55/126 50/222 | 105 | 126 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S12948 R49134 |
Engelstad (Controls unexposed, sick), 2014 | Admission to the neonatal intensive care unit (NICU) | during pregnancy (anytime or not specified) | retrospective cohort | unexposed, sick | Adjustment: No Monotherapy: SSRI only | 1.17 [0.71;1.93] C | 55/126 51/128 | 106 | 126 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S13258 R51065 |
Smith, 2013 | Neonatal intensive care unit (NICU) | 3rd trimester | prospective cohort | unexposed, disease free | Adjustment: No Monotherapy: no or not specified | 2.85 [0.27;30.62] C | 1/6 4/61 | 5 | 6 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S5428 R20521 |
Colvin, 2012 | Intensive care unit admissions | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: No Monotherapy: no or not specified | 1.40 [1.26;1.55] | 438/3,764 8,125/94,561 | 8,563 | 3,764 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S5961 R15335 |
Grzeskowiak a (Controls unexposed, disease free), 2012 | Neonate admitted to hospital | during pregnancy (anytime or not specified) | retrospective cohort | unexposed, disease free excluded | Adjustment: Yes Monotherapy: SSRI only |
2.37 [1.76;3.19] excluded (control group) |
87/221 6,114/32,004 | 6,201 | 221 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S5367 R15330 |
Grzeskowiak a (Controls unexposed, sick), 2012 | Neonate admitted to hospital | during pregnancy (anytime or not specified) | retrospective cohort | unexposed, sick | Adjustment: Yes Monotherapy: SSRI only Unexposed sick: recent illness/treatment (during or juste before pregnancy or treatment stopped in view of pregnancy) | 1.92 [1.39;2.65] | 87/221 414/1,566 | 501 | 221 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S5395 R16288 |
Klieger-Grossmann - Escitalopram, 2012 | Neonatal intensive care unit admission | late pregnancy | prospective cohort | unexposed (general population or NOS) | Adjustment: No Matched Monotherapy: SSRI only | 1.32 [0.59;2.94] C | 14/172 12/191 | 26 | 172 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S5406 R15092 |
Calderon-Margalit, 2009 | Neonatal Intensiv Care Unit (NICU) | during pregnancy (anytime or not specified) | prospective cohort | unexposed (general population or NOS) | Adjustment: Yes Monotherapy: no or not specified | 1.36 [0.70;2.67] | -/132 -/2,493 | - | 132 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S491 R16208 |
Lund (Controls unexposed, disease free), 2009 | Neonatal intensive care unit admission | during pregnancy (anytime or not specified) | prospective cohort | unexposed, disease free excluded | Adjustment: Yes Monotherapy: no or not specified |
2.39 [1.69;3.39] excluded (control group) |
54/329 3,845/51,770 | 3,899 | 329 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S6162 R16212 |
Lund (Controls unexposed, sick), 2009 | Neonatal intensive care unit admission | during pregnancy (anytime or not specified) | prospective cohort | unexposed, sick | Adjustment: No Monotherapy: no or not specified Unexposed sick: old history of illness/treatment (> 12 months before pregnancy) or not specified | 2.00 [1.47;2.72] C | 54/329 439/4,902 | 493 | 329 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S5408 R16600 |
Wisner (Controls unexposed, disease free), 2009 | Admission to Neonatal Intensive care unit | throughout pregnancy | prospective cohort | unexposed, disease free excluded | Adjustment: No Monotherapy: no or not specified |
2.77 [1.05;7.31] C excluded (control group) |
9/48 10/130 | 19 | 48 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S6249 R16608 |
Wisner (Controls unexposed, sick), 2009 | Admission to Neonatal Intensive care unit | throughout pregnancy | prospective cohort | unexposed, sick | Adjustment: No Monotherapy: no or not specified Unexposed sick: recent illness/treatment (during or juste before pregnancy or treatment stopped in view of pregnancy) | 0.85 [0.19;3.67] C | 9/48 3/14 | 12 | 48 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S7288 R21081 |
Maschi - Paroxetine, 2008 | Neonatal Intensive Care Unit (NICU)/Special Care Nursery (SCN) admissions | during pregnancy (anytime or not specified) | prospective cohort | unexposed (general population or NOS) | Adjustment: No Matched Monotherapy: no or not specified | 1.00 [0.12;8.46] C | 1/58 6/348 | 7 | 58 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S5394 R20677 |
Davis, 2007 | Respiratory distress syndrome and other respiratory conditions | 3rd trimester | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: No Monotherapy: no or not specified | 1.97 [1.65;2.35] | 112/874 5,300/75,219 | 5,412 | 874 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S15011 R61495 |
Lennestal, 2007 | Respiratory problems (Includes a diagnosis of respiratory problems and/or use of mechanical ventilation or continuous positive airway pressure) | late pregnancy | population based cohort retrospective | unexposed (general population or NOS) | Adjustment: Yes Monotherapy: no or not specified | 1.72 [1.41;2.11] | 99/- -/- | - | - |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S11220 R41289 |
Pearson (Controls exposed to TCA), 2007 | Admission in Special care nursery of neonatal intensive care unit | during pregnancy (anytime or not specified) | retrospective cohort | exposed to other treatment, sick excluded | Adjustment: No Monotherapy: SSRI only |
0.32 [0.10;1.03] C excluded (control group) |
5/42 11/37 | 16 | 42 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S11219 R41286 |
Pearson (Controls unexposed, NOS), 2007 | Admission in Special care nursery of neonatal intensive care unit | during pregnancy (anytime or not specified) | retrospective cohort | unexposed (general population or NOS) | Adjustment: No Monotherapy: SSRI only | 1.20 [0.42;3.46] C | 5/42 17/168 | 22 | 42 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S5989 R17674 |
Suri, 2007 | Special care nursery admission | during pregnancy (anytime or not specified) | prospective cohort | unexposed, disease free | Adjustment: No Monotherapy: no or not specified | 10.36 [0.58;186.64] C | 10/48 0/19 | 10 | 48 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S5405 R16053 |
Wen, 2006 | Mechanical ventilation in neonates | 3 months (or more) before pregnancy or during pregnancy excluded | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: Yes Matched Monotherapy: no or not specified |
1.14 [0.74;1.75] excluded (exposition period) |
34/972 87/3,878 | 121 | 972 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S508 R17594 |
Sivojelezova - Citalopram, 2005 | Neonatal intensive care unit admission | 3rd trimester | prospective cohort | unexposed (general population or NOS) | Adjustment: No Matched Monotherapy: no or not specified | 4.20 [1.70;10.30] | 10/63 6/158 | 16 | 63 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S7969 R24468 |
Oberlander, 2004 | Poor neonatal adaptation (high level of medical care and observation) | during pregnancy (anytime or not specified) | prospective cohort | unexposed, disease free | Adjustment: No Monotherapy: SSRI only | 3.50 [0.65;18.85] C | 7/28 2/23 | 9 | 28 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S7764 R22971 |
Suri - Fluoxetine (Controls unexposed, disease free), 2004 | Neonatal Intensive Care Unit (NICU) admissions | during pregnancy (anytime or not specified) | prospective cohort | unexposed, disease free excluded | Adjustment: No Monotherapy: SSRI only |
0.52 [0.09;2.95] C excluded (control group) |
3/28 3/16 | 6 | 28 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S7581 R22970 |
Suri - Fluoxetine (Controls unexposed, sick), 2004 | Neonatal Intensive Care Unit (NICU) admissions | during pregnancy (anytime or not specified) | prospective cohort | unexposed, sick | Adjustment: No Monotherapy: SSRI only Unexposed sick: old history of illness/treatment (> 12 months before pregnancy) or not specified | 0.96 [0.14;6.39] C | 3/28 2/18 | 5 | 28 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S510 R15166 |
Casper, 2003 | Admission to neonatal intensive care units | during pregnancy (anytime or not specified) | prospective cohort | unexposed, sick | Adjustment: No Monotherapy: no or not specified Unexposed sick: recent illness/treatment (during or juste before pregnancy or treatment stopped in view of pregnancy) | 7.98 [0.42;151.51] C | 7/31 0/13 | 7 | 31 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S5954 R15276 |
Costei - Paroxetine (Controls unexposed, NOS), 2002 | Neonate respiratory distress | 3rd trimester | prospective cohort | unexposed (general population or NOS) excluded | Adjustment: No Matched Monotherapy: no or not specified |
11.07 [0.62;197.91] C excluded (control group) |
9/55 0/27 | 9 | 55 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S5953 R15272 |
Costei - Paroxetine (Controls unexposed, sick), 2002 | Neonate respiratory distress | 3rd trimester | prospective cohort | unexposed, sick | Adjustment: No Matched Monotherapy: no or not specified Unexposed sick: recent illness/treatment (during or juste before pregnancy or treatment stopped in view of pregnancy) | 5.09 [0.61;42.43] C | 9/55 1/27 | 10 | 55 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| S490 R15172 |
Chambers - Fluoxetine, 1996 | Admission to a special-care nursery | late pregnancy | prospective cohort | unexposed (general population or NOS) | Adjustment: No Monotherapy: no or not specified | 4.74 [2.41;9.30] C | 23/73 20/226 | 43 | 73 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total | 36 studies | 1.84 [1.63;2.07] | 106,889 | 61,231 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1: Controls unexposed, general pop; 2: Controls exposed to Bupropion; 3: Controls unexposed, sick; 4: Controls unexposed, sick; 5: Controls unexposed, sick; 6: Controls unexposed, sick; 7: Controls unexposed, sick; 8: Controls unexposed, sick; 9: Controls unexposed, sick; 10: Controls unexposed, sick; 11: Controls unexposed, NOS; 12: Controls unexposed, sick; 13: Controls unexposed, sick;
Asymetry test p-value = 0.0068 (by Egger's regression)
slope=0.4326 (0.0485); intercept=0.9127 (0.5378); t=1.6972; p=0.0068
excluded 5954, 7764, 11220, 491, 5408, 5961, 12947, 6107, 8053, 7921, 12918, 8158, 18442